Navigation Links
ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results
Date:11/2/2010

will be at the lower end of the 18% to 22% range of net revenues, due to the timing of its clinical programs.
  • ISTA expects SG&A expenses will be at the higher end of the 48% to 52% range of net revenues due to launch expenses for BROMDAY.  On a dollar basis, ISTA expects SG&A expenses in the fourth quarter of 2010 to be higher than third quarter due to BROMDAY launch costs.

  • ISTA's expectations for operating income are unchanged at approximately $8 million to $10 million.

  • ISTA expects 2010 to be its first year of profitability with net income of at least $1 million, or earnings per share of $0.02, excluding any non-cash warrant valuation adjustments.  As of September 30, 2010, ISTA's fully diluted common shares, including its outstanding shares of common stock plus warrants and stock options on a treasury stock basis were approximately 43 million shares.

  • ISTA expects its year-end cash balance to be at least $70 million including amounts borrowed under its revolving credit facility with Silicon Valley Bank. Included in the year-end cash balance estimate is $20 million to $25 million in reserved bromfenac royalties.

  • ISTA Provides 2011 Net Revenues Outlook

    ISTA expects its 2011 net revenues to be in the range of $175 million to $190 million.  The company will provide further guidance on 2011 when ISTA reports its 2010 full year results.

    Update on Bromfenac Patent Litigation

    On August 26, 2010, the U.S. District Court for the Central District of California, stayed the legal action filed in April 2010 by ISTA Pharmaceuticals, Inc. ("ISTA") against Senju Pharmaceutical, Co. Ltd. ("Senju"), in which ISTA seeks, among other remedies, a declaratory judgment that no further royalties are due to Senju related to XIBROM (bromfenac), following a relevant patent's expiration in January 2009. Legal action was stayed pending arbitration upon Senju's request.  In Septemb
    '/>"/>

    SOURCE ISTA Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. DUSA Pharmaceuticals, Inc.® to Host Third Quarter 2010 Corporate Highlights and Financial Results Conference Call
    2. Access Pharmaceuticals Awarded $1.5 Million in Section 48D Grants
    3. Anadys Pharmaceuticals to Report Third Quarter 2010 Financial Results
    4. Alder Biopharmaceuticals Appoints Bruce Montgomery to Board of Directors
    5. Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010
    6. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
    7. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
    8. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2010 Financial Results on November 5, 2010
    9. Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2010 Financial Results
    10. VIDEO from thenewsmarket.com and Roche Pharmaceuticals: MabThera Approved in Europe for First Line Maintenance Treatment of Follicular Lymphoma, a Common Type of Blood Cancer
    11. MAP Pharmaceuticals to Present Data Showing Low Migraine Recurrence Rates With LEVADEX™ in FREEDOM-301 Trial
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2014)... COLORADO SPRINGS, Colo. , July 29, 2014 /PRNewswire-USNewswire/ ... remote-controlled catheter (MARC) which could allow physicians to see ... stroke may hold promise, according to study authors who ... Surgery (SNIS) 11 th Annual Meeting in ... findings stand to advance the field of neurointervention, a ...
    (Date:7/29/2014)... and NEW YORK , ... of the executive management team of Caremark Rx, ... Media ( www.pbm365.com ).  PBM365 is the leading independent ... reporting, insight, analysis and opinion on the pharmacy ... will provide insightful and timely coverage of, and context ...
    (Date:7/29/2014)... , July 29, 2014  Roche (SIX: RO, ... Association for Clinical Chemistry (AACC) 2014 Clinical Lab Expo ... on the unique ways Roche is partnering with customers ... "Our customers tell us every day that they,re looking ... they deliver in their labs and offices," said ...
    Breaking Medicine Technology:New Technology May Improve Visualization Of The Brain During Stroke Treatment 2New Technology May Improve Visualization Of The Brain During Stroke Treatment 3Drew Crawford Announces Launch of PBM365 Media 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4
    ... June 15, 2011 The American Academy of ... 2011 AAFP Foundation Pfizer Immunization Award winners. These ... achieved increased immunization rates in their communities through ... the AAFP,s National Conference were presented to 16 ...
    ... June 15, 2011 To address surgeons, need for ... in open surgery, Ethicon Endo-Surgery, Inc. (EES) today announces ... advanced bipolar technology.  The new technology is designed with ... sealing vessels consistently along the length of the 40mm ...
    Cached Medicine Technology:Family Medicine Residency Programs Recognized for Improving Childhood and Adult Immunizations Rates in Underserved Communities 2Family Medicine Residency Programs Recognized for Improving Childhood and Adult Immunizations Rates in Underserved Communities 3Ethicon Endo-Surgery Launches ENSEAL® G2 Super Jaw 2
    (Date:7/29/2014)... (PRWEB) July 29, 2014 Biocides are ... and control bacteria or fungi growth and to prevent ... within the material and its surface. It is used ... wood preservation, food and beverage, paints and coatings. It ... and sanitizers, as well as in industrial applications to ...
    (Date:7/29/2014)... The U.S. should significantly reform the federal system ... ensure that the public,s $15 billion annual investment ... says a new report by the Institute of ... Medicare -- requires little accountability, allocates funds independent ... insufficient opportunities to train physicians in the health ...
    (Date:7/29/2014)... (PRWEB) July 29, 2014 Frank Davis, ... powders can help parents add nutrition to their kids’ ... Bites – Key market drivers in kids’ foods market” ... is pleased to announce the interview Frank Davis had ... the Activz organic vegetable and fruit produce powders to ...
    (Date:7/29/2014)... State College of Medicine, have jointly received nearly ... data research network., The Patient-Centered Outcomes Research Institute ... and Affordable Care Act, awarded the funds to ... Johns Hopkins University -- and each of their ... together to create a Clinical Data Research Network, ...
    (Date:7/29/2014)... July 29, 2014 According to a ... the leading global authority in medical device market research, ... grow to over $8 billion by 2018. This ... in the transcatheter heart valve market, which is comprised ... the transcatheter mitral valve repair (TMVR) segments. , There ...
    Breaking Medicine News(10 mins):Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 2Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 3Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 4Health News:$15 billion annual public funding system for doctor training needs overhaul, says IOM 2Health News:$15 billion annual public funding system for doctor training needs overhaul, says IOM 3Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 2Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 3Health News:New network unites university health care research 2Health News:Global Transcatheter Heart Valve Devices Market Outlook to 2018: Breakthrough Developments led by Abbott, Edwards LifeSciences and Medtronic 2Health News:Global Transcatheter Heart Valve Devices Market Outlook to 2018: Breakthrough Developments led by Abbott, Edwards LifeSciences and Medtronic 3
    ... officials have proposed the administration of flu vaccine to all ... attempt to prevent the incidence of seasonal flu. The dreadful ... during winter, had claimed the valuable lives of over 1000 ... Vaccination and Immunisation that addresses important medical issues and provides ...
    ... women who suffer from stage 1 endometrial cancer along with ... says// that this can prolong their survival. Among the gynecological ... As many as 40,000 women in the US suffer from ... data of the American Cancer Society. ,The ...
    ... are reforming themselves to come out of the financial ... Patricia Hewitt, British Health secretary as welcomed better financial ... more on cutting unnecessary fund wastage. ... for all the NHS hospitals will be followed and ...
    ... arrest in supply of blood to the brain cells, which occurs ... caused by a blocked artery and Hemorrhagic stroke is caused due ... sudden stopping of blood to the brain cells can lead to ... stroke, the survival of the stroke patients depend upon the severity ...
    ... the level of mental sharpness in aging individuals, according ... at Lowell//. , The researchers assessed whether ... aging mice, damage that can lead to memory loss. ... mice using a standard diet, a nutrient-deficient diet, and ...
    ... 250,000 early-stage glaucoma patients risk blindness due to lack of ... National Institute for the Blind (RNIB).// In an attempt to ... has been launched in the UK. ,Apart from ... from some form of visual impairment in the UK. The ...
    Cached Medicine News:
    ... Certified by an independent laboratory ... of Federal Standard 209E. Ergonomic ... fatique and back injuries. Clean ... requirements. Static-control chairs feature dissipative ...
    ... SCE offers a full line of ... manufacturing and laboratory environments. Every SCE product ... / safety requirements. Now you can have ... hazardous acid / corrosive chemicals and materials ...
    ... Genie is an all-in-one rotator/rocker with ... five different mixing motions: rotating, ... well as a combination of all ... portion of the Vibraotme Roto-Shake Genie ...
    ... 55S Rocking Shaker provides the exact ... membranes. The very slow to fast ... tilt provide a gentle wave motion ... and blotted membranes to achieve faster, ...
    Medicine Products: